How many institutions held LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in Q2 2025?

160 institutional investors reported LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share for Q2 2025. Use the holders table for investor-level position and value details.

STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB)

Q: What does CUSIP 34385P108 represent in this 13F holders report?

CUSIP 34385P108 is the security identifier for LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 34385P108

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 384,731,503
Total 13F shares: 280,617,967
Share change: -984,688
Total reported value: $336,678,756
Put/Call ratio: 0%
Price per share: $1.20
Number of holders: 160
Value change: -$1,077,649
Number of buys: 76
Number of sells: 57

Quarterly Holders Quick Answers

What is CUSIP 34385P108?
CUSIP 34385P108 identifies LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 34385P108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LAB - STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Casdin Capital, LLC	13F	Company	20%	76,075,636	$82,161,687	—	31 Mar 2025	13F
VIKING GLOBAL INVESTORS LP	13F 3/4/5	Company · 10%+ Owner	15%	58,651,170	$63,343,264	—	31 Mar 2025	13F 3/4/5
Caligan Partners LP	3/4/5	10%+ Owner	— mixed-class rows	16,265,374 mixed-class rows	$34,539,714	—	29 Jun 2023	3/4/5
BlackRock, Inc.	13F	Company	6.4%	24,620,271	$26,589,891	—	31 Mar 2025	13F
VANGUARD GROUP INC	13F	Company	4.5%	17,225,250	$18,603,270	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	2.8%	10,710,678	$11,567,533	—	31 Mar 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.9%	7,205,457	$7,783,621	—	31 Mar 2025	13F
Long Focus Capital Management, LLC	13F	Company	1.7%	6,700,000	$7,236,000	—	31 Mar 2025	13F
Tikvah Management LLC	13F	Company	1.7%	6,551,058	$7,075,143	—	31 Mar 2025	13F
STATE STREET CORP	13F	Company	1.7%	6,359,129	$6,867,859	—	31 Mar 2025	13F
Amova Asset Management Americas, Inc.	13F	Company	1.6%	6,233,693	$6,732,388	—	31 Mar 2025	13F
Sumitomo Mitsui Trust Group, Inc.	13F	Company	1.6%	6,233,693	$6,732,388	—	31 Mar 2025	13F
Hollow Brook Wealth Management LLC	13F	Company	1.4%	5,553,381	$5,997,651	—	31 Mar 2025	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.3%	5,073,335	$5,479,202	—	31 Mar 2025	13F
Neuberger Berman Group LLC	13F	Company	1.2%	4,518,608	$4,899,825	—	31 Mar 2025	13F
ARK Investment Management LLC	13F	Company	0.9%	3,452,890	$3,729,121	—	31 Mar 2025	13F
MIRABELLA FINANCIAL SERVICES LLP	13F	Company	0.85%	3,270,673	$3,532,327	—	31 Mar 2025	13F
BARCLAYS PLC	13F	Company	0.81%	3,100,539	$3,348,582	—	31 Mar 2025	13F
NORTHERN TRUST CORP	13F	Company	0.72%	2,784,979	$3,007,779	—	31 Mar 2025	13F
MAK CAPITAL ONE LLC	13F	Company	0.72%	2,774,721	$2,996,699	—	31 Mar 2025	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.64%	2,443,060	$2,638,505	—	31 Mar 2025	13F
Jeffrey G. Black	3/4/5	SVP & Chief Financial Officer	— mixed-class rows	966,346 mixed-class rows	$2,532,070	—	20 Aug 2024	3/4/5
ROYCE & ASSOCIATES LP	13F	Company	0.52%	2,000,503	$2,160,543	—	31 Mar 2025	13F
Nan Fung Group Holdings Ltd	13F	Company	0.49%	1,883,179	$2,033,833	—	31 Mar 2025	13F
Slate Path Capital LP	13F	Company	0.42%	1,615,000	$1,744,200	—	31 Mar 2025	13F
Pacific Capital Partners Ltd	13F	Company	0.41%	1,575,000	$1,701,000	—	31 Mar 2025	13F
Casdin Amplify Fund, LP	3/4/5	Director	— class O/S missing	545,000	$1,117,250	—	18 Jun 2024	3/4/5
Stephen Christopher Linthwaite	3/4/5	President & CEO	— mixed-class rows	390,252 mixed-class rows	$1,004,213	—	22 Feb 2022	3/4/5
Nuveen, LLC	13F	Company	0.21%	798,482	$862,361	—	31 Mar 2025	13F
Bank of New York Mellon Corp	13F	Company	0.19%	732,869	$791,499	—	31 Mar 2025	13F
Vikram Jog	3/4/5	Chief Financial Officer	— mixed-class rows	297,859 mixed-class rows	$762,479	—	21 Feb 2023	3/4/5
GOLDMAN SACHS GROUP INC	13F	Company	0.18%	676,529	$730,651	—	31 Mar 2025	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	0.16%	632,074	$682,640	—	31 Mar 2025	13F
Jeremy Steven Davis	3/4/5	SVP Chief Commercial Officer	— mixed-class rows	243,824 mixed-class rows	$667,438	—	21 Feb 2023	3/4/5
GSA CAPITAL PARTNERS LLP	13F	Company	0.16%	608,656	$657,000	—	31 Mar 2025	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.14%	554,203	$598,539	—	31 Mar 2025	13F
NEEDHAM INVESTMENT MANAGEMENT LLC	13F	Company	0.14%	534,435	$577,190	—	31 Mar 2025	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.13%	482,912	$521,545	—	31 Mar 2025	13F
Fenel M. Eloi	3/4/5	Director	— mixed-class rows	361,843 mixed-class rows	$520,430	—	20 Jun 2025	3/4/5
Nicolas Barthelemy	3/4/5	Director	— class O/S missing	204,077	$518,356	—	01 Apr 2022	3/4/5
Frank Witney	3/4/5	Director	— mixed-class rows	340,747 mixed-class rows	$498,068	—	20 Jun 2025	3/4/5
Swiss National Bank	13F	Company	0.11%	437,960	$472,997	—	31 Mar 2025	13F
Carlos Paya V	3/4/5	Director	— mixed-class rows	162,224 mixed-class rows	$454,505	—	14 Jun 2023	3/4/5
Qube Research & Technologies Ltd	13F	Company	0.11%	420,122	$453,732	—	31 Mar 2025	13F
RHUMBLINE ADVISERS	13F	Company	0.11%	412,761	$445,774	—	31 Mar 2025	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.11%	407,755	$440,375	—	31 Mar 2025	13F
UBS Group AG	13F	Company	0.11%	406,988	$439,547	—	31 Mar 2025	13F
Intellectus Partners, LLC	13F	Company	0.11%	404,702	$437,078	—	31 Mar 2025	13F
Kathy L. Hibbs	3/4/5	Director	— mixed-class rows	263,380 mixed-class rows	$416,060	—	20 Jun 2025	3/4/5
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.1%	381,453	$411,969	—	31 Mar 2025	13F

Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q2 2025

As of 30 Jun 2025, STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by 160 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 280,617,967 shares. The largest 10 holders included Casdin Capital, LLC, VIKING GLOBAL INVESTORS LP, BlackRock, Inc., VANGUARD GROUP INC, Long Focus Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, MORGAN STANLEY, Sumitomo Mitsui Trust Group, Inc., and Nikko Asset Management Americas, Inc.. This page lists 159 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

146

Q2 2025 holders

160

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.